Literature DB >> 27910095

A comparison of methods for estimating the incidence of human immunodeficiency virus infection in repeat blood donors.

Donald J Brambilla1, Michael P Busch2, Roger Y Dodd3, Simone A Glynn4, Steven H Kleinman5.   

Abstract

BACKGROUND: The incidence of human immunodeficiency virus (HIV) in repeat blood donors has been estimated using seven methods. Although incidence is always calculated as cases per person-time, approaches to selecting cases and calculating person-time vary. Incidence estimates have not been compared among methods. STUDY DESIGN AND METHODS: The seven methods were compared in a simulation study. Because three methods used information from donations made before an estimation interval, 8 years of donation and infection history were simulated, and Years 7 and 8 were treated as the estimation interval for all methods. An exponential random variate was assigned to each donor to simulate the time to infection. Infection risk was constant over 8 years in one scenario but increased at various rates in seven other scenarios. The infection risk scenarios were combined with four mixes of donation frequency to generate 32 test conditions.
RESULTS: Three methods produced biased estimates under all conditions. Three other methods were biased under most conditions. Bias from most methods increased as donation frequency declined. The single method that consistently produced unbiased estimates was the only method that involved the standard epidemiological approach of tabulating all interdonation intervals (IDIs) within the estimation interval. Bias was eliminated from one of the consistently biased methods by a simple modification that involved the average IDI in a sample of donors.
CONCLUSION: The standard epidemiological approach is recommended if required data are available. Otherwise, the modified method involving the estimated average IDI should be considered. Investigators should use caution when comparing incidence estimates among studies that use different estimation methods or donation frequencies.
© 2016 AABB.

Entities:  

Mesh:

Year:  2016        PMID: 27910095      PMCID: PMC5368013          DOI: 10.1111/trf.13939

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  17 in total

1.  Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services.

Authors:  S F O'Brien; Q-L Yi; W Fan; V Scalia; M A Fearon; J-P Allain
Journal:  Vox Sang       Date:  2012-01-31       Impact factor: 2.144

2.  Incidence of viral markers and evaluation of the estimated risk in the Swiss blood donor population from 1996 to 2003.

Authors:  C Niederhauser; P Schneider; M Fopp; A Ruefer; G Lévy
Journal:  Euro Surveill       Date:  2005-02

3.  Human immunodeficiency virus prevalence, incidence, and residual risk of transmission by transfusions at Retrovirus Epidemiology Donor Study-II blood centers in Brazil.

Authors:  Ester C Sabino; Thelma T Gonçalez; Anna Bárbara Carneiro-Proietti; Moussa Sarr; João Eduardo Ferreira; Divaldo A Sampaio; Nanci A Salles; David J Wright; Brian Custer; Michael Busch
Journal:  Transfusion       Date:  2011-10-07       Impact factor: 3.157

4.  Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.

Authors:  Sheila F O'Brien; Qi-Long Yi; Wenli Fan; Vito Scalia; Steven H Kleinman; Eleftherios C Vamvakas
Journal:  Transfusion       Date:  2007-02       Impact factor: 3.157

5.  Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.

Authors:  Laila Al Shaer; Mahera AbdulRahman; Thomas J John; Ali AlHashimi
Journal:  Transfusion       Date:  2012-06-13       Impact factor: 3.157

6.  Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001.

Authors:  K Soldan; J A J Barbara; M E Ramsay; A J Hall
Journal:  Vox Sang       Date:  2003-05       Impact factor: 2.144

7.  Prevalence, incidence, and residual risks for transfusion-transmitted human immunodeficiency virus Types 1 and 2 infection among Chinese blood donors.

Authors:  Jingxing Wang; Jing Liu; Fuzhu Yao; Guoxin Wen; Julin Li; Yi Huang; Yunlai Lü; Xiuqiong Wen; David Wright; Qilu Yu; Nan Guo; Paul Ness; Hua Shan
Journal:  Transfusion       Date:  2012-11-01       Impact factor: 3.157

8.  The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study.

Authors:  G B Schreiber; M P Busch; S H Kleinman; J J Korelitz
Journal:  N Engl J Med       Date:  1996-06-27       Impact factor: 91.245

9.  Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States.

Authors:  E M Lackritz; G A Satten; J Aberle-Grasse; R Y Dodd; V P Raimondi; R S Janssen; W F Lewis; E P Notari; L R Petersen
Journal:  N Engl J Med       Date:  1995-12-28       Impact factor: 91.245

10.  Human immunodeficiency virus prevalence, incidence, and residual transmission risk in first-time and repeat blood donations in Zimbabwe: implications on blood safety.

Authors:  Tonderai Mapako; David A Mvere; McLeod E Chitiyo; Simbarashe Rusakaniko; Maarten J Postma; Marinus van Hulst
Journal:  Transfusion       Date:  2013-06-23       Impact factor: 3.157

View more
  2 in total

1.  Prevalence, incidence and residual risk of transfusion-transmitted hepatitis C virus and human immunodeficiency virus after the implementation of nucleic acid testing in Italy: a 7-year (2009-2015) survey.

Authors:  Claudio Velati; Luisa Romanò; Vanessa Piccinini; Giuseppe Marano; Liviana Catalano; Simonetta Pupella; Giuseppina Facco; Ilaria Pati; Maria Elena Tosti; Stefania Vaglio; Giuliano Grazzini; Alessandro Zanetti; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2018-06-26       Impact factor: 3.443

2.  10-year analysis of human immunodeficiency virus incidence in first-time and repeat donors in Brazil.

Authors:  Sheila de Oliveira Garcia Mateos; Liliana Preiss; Thelma T Gonçalez; Claudia Di Lorenzo Oliveira; Eduard Grebe; Clara Di Germanio; Mars Stone; Luiz Amorim Filho; Anna Bárbara Carneiro Proietti; Andre Rolim Belisario; Cesar de Almeida-Neto; Alfredo Mendrone-Junior; Paula Loureiro; Michael P Busch; Brian Custer; Ester Cerdeira Sabino
Journal:  Vox Sang       Date:  2020-09-30       Impact factor: 2.144

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.